NCT04072107 2023-06-18
EP-STAR
Sun Yat-sen University
Phase 2 Unknown
Clinical Trials
9 trialsNCT05549466 2023-02-08
Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC
Sun Yat-sen University
Phase 2 Unknown
NCT05201859 2022-05-06
Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT04220528 2020-01-07
Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC
Fujian Cancer Hospital
Phase 2 Unknown
NCT02958111 2019-06-12
CAN
Sun Yat-sen University
Phase 3 Unknown
NCT02786641 2016-06-01
Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT02633176 2015-12-17
Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT02621970 2015-12-04
Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT00577057 2013-08-22
Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
Hospital Authority, Hong Kong
Phase NA Unknown